Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06696209Not ApplicableRecruiting

To Evaluate the Best Metric for Inspection Time During a Diagnostic and/or Surveillance Upper Gastrointestinal Endoscopy (Age ≥ 18 Years, Informed Consent), Between Total Inspection Time Versus Withdrawal Time, for the Identification of Malignant Lesions

Role: lead

NCT06143189Not ApplicableCompleted

Well-being Biomarkers (BIOSMILE) & Psychology Analyses in Women With Cancer After Hospital Clowns and Hosting Effects

Role: collaborator

NCT04239365Not ApplicableCompleted

Follow-up Protocol of Colorectal Endoscopic Mucosal Resection Scars

Role: lead

NCT03816774Not ApplicableCompleted

Effect of Adding Simethicone to Split-dose Polyethylene Glycol for Bowel Preparation in a Screening Colonoscopy Setting

Role: lead

NCT04378088Completed

The Colon Endoscopic Bubble Scale (CEBuS); Validation Study

Role: lead

NCT02955901Not ApplicableCompleted

3-day vs. 1-day Low Residue Diet Influence in Colonoscopy Preparation and Patient Tolerability

Role: lead

NCT02357303Phase 4Completed

Simethicone and N-acetylcysteine in Upper Endoscopy - Prospective Double-blinded Randomized Controlled Trial

Role: lead

All 7 trials loaded